New developments in the management of narcolepsy
Vivien C Abad, Christian Guilleminault Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine, Stanford University Outpatient Center, Redwood City, CA, USA Abstract: Narcolepsy is a life-long, underrecognized sleep disorder that affects 0.02%–0.18% of the US...
Guardado en:
Autores principales: | Abad VC, Guilleminault C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b15a6738adbc4be08828fb343f6c8a93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment paradigms for cataplexy in narcolepsy: past, present, and future
por: Swick TJ
Publicado: (2015) -
Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns
por: Barker EC, et al.
Publicado: (2020) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
por: Vellieux G, et al.
Publicado: (2021) -
Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra JT, et al.
Publicado: (2020) -
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
por: Calik MW
Publicado: (2017)